Trial Profile
Effect Of Zoledronic Acid On Circulating And Bone Marrow-Residing Prostate Cancer Cells In Patients With Clinically Localized Prostate Cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Jun 2017
Price :
$35
*
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Sponsors Novartis
- 30 Apr 2012 Actual end date (Apr 2012) added as reported by ClinicalTrials.gov.
- 03 Jun 2009 New trial record.